John G Ullman & Associates Inc. Has $4.30 Million Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

John G Ullman & Associates Inc. lowered its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,043 shares of the company’s stock after selling 438 shares during the period. John G Ullman & Associates Inc.’s holdings in GE HealthCare Technologies were worth $4,303,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of GEHC. Assenagon Asset Management S.A. increased its holdings in shares of GE HealthCare Technologies by 10.1% in the third quarter. Assenagon Asset Management S.A. now owns 13,735 shares of the company’s stock valued at $1,289,000 after purchasing an additional 1,256 shares in the last quarter. US Bancorp DE increased its holdings in shares of GE HealthCare Technologies by 0.9% in the third quarter. US Bancorp DE now owns 296,382 shares of the company’s stock valued at $27,815,000 after purchasing an additional 2,664 shares in the last quarter. Cigna Investments Inc. New increased its holdings in shares of GE HealthCare Technologies by 4.4% in the third quarter. Cigna Investments Inc. New now owns 4,558 shares of the company’s stock valued at $428,000 after purchasing an additional 193 shares in the last quarter. Farther Finance Advisors LLC increased its holdings in shares of GE HealthCare Technologies by 10.9% in the third quarter. Farther Finance Advisors LLC now owns 4,520 shares of the company’s stock valued at $424,000 after purchasing an additional 443 shares in the last quarter. Finally, Mathes Company Inc. increased its holdings in shares of GE HealthCare Technologies by 196.9% in the third quarter. Mathes Company Inc. now owns 49,251 shares of the company’s stock valued at $4,622,000 after purchasing an additional 32,665 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 2.3 %

Shares of NASDAQ:GEHC opened at $87.35 on Friday. GE HealthCare Technologies Inc. has a 12 month low of $74.51 and a 12 month high of $94.80. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company’s fifty day simple moving average is $86.17 and its 200 day simple moving average is $86.12. The firm has a market cap of $39.94 billion, a price-to-earnings ratio of 20.17, a PEG ratio of 3.19 and a beta of 1.15.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Wall Street Analyst Weigh In

GEHC has been the topic of a number of recent research reports. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $97.67.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.